Surgical delivery of clot-busting drug has benefits, study finds

02/8/2013 | HealthDay News

Researchers tracked 96 patients with intracerebral hemorrhage and found that those who underwent surgery to receive the clot-busting drug tissue plasminogen activator, or tPA, directly in their brains recovered faster than those who received standard therapy. Patients who received tPA were discharged an average of 38 days earlier and their blood clots dissolved faster. The study appears in the journal Stroke.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC